Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

478 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Pulse cyclophosphamide in the treatment of neuropsychiatric systemic lupus erythematosus.
Ramos PC, Mendez MJ, Ames PR, Khamashta MA, Hughes GR. Ramos PC, et al. Among authors: khamashta ma. Clin Exp Rheumatol. 1996 May-Jun;14(3):295-9. Clin Exp Rheumatol. 1996. PMID: 8809444 Clinical Trial.
Targeted therapies in systemic lupus erythematosus.
Grech P, Khamashta M. Grech P, et al. Among authors: khamashta m. Lupus. 2013 Sep;22(10):978-86. doi: 10.1177/0961203313499417. Lupus. 2013. PMID: 23963429 Review.
Estrogen and progesterone receptors in murine models of systemic lupus erythematosus.
Greenstein B, Roa R, Dhaher Y, Nunn E, Greenstein A, Khamashta M, Hughes GR. Greenstein B, et al. Among authors: khamashta m. Int Immunopharmacol. 2001 Jun;1(6):1025-35. doi: 10.1016/s1567-5769(01)00034-0. Int Immunopharmacol. 2001. PMID: 11407299 Review.
BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus.
Isenberg DA, Rahman A, Allen E, Farewell V, Akil M, Bruce IN, D'Cruz D, Griffiths B, Khamashta M, Maddison P, McHugh N, Snaith M, Teh LS, Yee CS, Zoma A, Gordon C. Isenberg DA, et al. Among authors: khamashta m. Rheumatology (Oxford). 2005 Jul;44(7):902-6. doi: 10.1093/rheumatology/keh624. Epub 2005 Apr 6. Rheumatology (Oxford). 2005. PMID: 15814577
Lymphocyte activation markers and von Willebrand factor antigen in Wegener's granulomatosis: potential markers for disease activity.
D'Cruz D, Direskeneli H, Khamashta M, Hughes GR. D'Cruz D, et al. Among authors: khamashta m. J Rheumatol. 1999 Jan;26(1):103-9. J Rheumatol. 1999. PMID: 9918249
Interethnic differences in the association of tumor necrosis factor promoter polymorphisms with systemic lupus erythematosus.
Rudwaleit M, Tikly M, Khamashta M, Gibson K, Klinke J, Hughes G, Wordsworth P. Rudwaleit M, et al. Among authors: khamashta m. J Rheumatol. 1996 Oct;23(10):1725-8. J Rheumatol. 1996. PMID: 8895148
Antiendothelial cell antibodies (AECA) in systemic lupus erythematosus (SLE).
D'Cruz D, Khamashta M, Hughes G. D'Cruz D, et al. Among authors: khamashta m. Clin Rev Allergy Immunol. 1997 Spring;15(1):53-63. doi: 10.1007/BF02828277. Clin Rev Allergy Immunol. 1997. PMID: 9209801 Review. No abstract available.
Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review.
Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, Khamashta MA. Ruiz-Irastorza G, et al. Among authors: khamashta ma. Ann Rheum Dis. 2010 Jan;69(1):20-8. doi: 10.1136/ard.2008.101766. Ann Rheum Dis. 2010. PMID: 19103632 Review.
BILAG-2004 index captures systemic lupus erythematosus disease activity better than SLEDAI-2000.
Yee CS, Isenberg DA, Prabu A, Sokoll K, Teh LS, Rahman A, Bruce IN, Griffiths B, Akil M, McHugh N, D'Cruz D, Khamashta MA, Maddison P, Zoma A, Gordon C. Yee CS, et al. Among authors: khamashta ma. Ann Rheum Dis. 2008 Jun;67(6):873-6. doi: 10.1136/ard.2007.070847. Epub 2007 May 22. Ann Rheum Dis. 2008. PMID: 17519277
Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis.
Alba P, Bento L, Cuadrado MJ, Karim Y, Tungekar MF, Abbs I, Khamashta MA, D'Cruz D, Hughes GR. Alba P, et al. Among authors: khamashta ma. Ann Rheum Dis. 2003 Jun;62(6):556-60. doi: 10.1136/ard.62.6.556. Ann Rheum Dis. 2003. PMID: 12759294 Free PMC article.
478 results
Jump to page